Pharmaceutical Root Cause Analysis of Failures & Deviations - Developing an Effective CAPA Strategy

Course Overview

In today’s highly regulated pharmaceutical environment, ineffective investigations and weak CAPA systems remain one of the leading causes of FDA observations and compliance failures.

This practical, results-driven training is designed to help professionals identify true root causes, avoid recurring deviations, and implement robust, inspection-ready CAPA strategies.

You will gain a clear understanding of how to move beyond superficial fixes and develop data-driven, scientifically sound solutions that stand up to regulatory scrutiny.

Learning Objective

• How to conduct effective, unbiased investigations
• Proven tools and techniques for Root Cause Analysis (RCA)
• How to distinguish symptoms vs true root causes
• Designing strong corrective and preventive actions (CAPA)
• Applying risk-based approaches (ICH Q9 principles)
• Using data, trends, and statistical thinking in investigations
• Preparing inspection-ready documentation and reports

 Agenda

Day 1: Investigation & CAPA Fundamentals

👉 Build a strong foundation and understand regulatory expectations

Key Topics:

• What is an Investigation?
• Correction vs Corrective Action vs Preventive Action (CAPA)
• Why CAPA fails in organizations
• Regulatory expectations (FDA, ICH, global trends)
• Understanding “Adulteration” & compliance risk
• Cost of poor investigations & CAPA failures

CAPA System Essentials:

• CAPA lifecycle & workflow
• Common CAPA challenges
• What makes a CAPA system effective

Interactive:

• Event characterization exercise
• Identifying bias in investigations

Day 2: Investigation Excellence & Root Cause Analysis (RCA)

👉 Learn how to identify the TRUE root cause — not just symptoms

Investigation Techniques:

• Data gathering & data integrity considerations
• Data mining & trend analysis
• GMP transactional mapping

Root Cause Analysis (RCA):

• Structured RCA approaches
• Signal detection & analysis
• Null hypothesis concept (thinking scientifically)
• Introduction to DOE (Design of Experiments)

Risk & Impact:

• ICH Q9 risk management principles
• Risk assessment tools (FMEA, etc.)
• Impact assessment for decision-making

Interactive:

• GMP awareness activity

Day 3: CAPA Development & Effectiveness

👉 Turn root causes into strong, audit-ready CAPAs

CAPA Planning:

• Linking root cause to CAPA
• Designing effective corrective & preventive actions
• Avoiding weak or superficial CAPAs

Execution & Implementation:

• Applying DOE for robust solutions
• Change management considerations
• Cross-functional CAPA execution

Effectiveness Checks:

• Defining success metrics (CAPA efficacy)
• Verification vs validation
• Preventing recurrence

Day 4: Real-World Case Studies & Inspection Readiness

👉 Apply learning to real pharmaceutical scenarios

Case Studies:

• scenario
• Product mix-up complaint (tablet issue)
• Media fill failure investigation

Hands-On Learning:

• End-to-end deviation → RCA → CAPA exercise
• Group discussion & solution approach

Inspection Readiness:

• Presenting investigations to FDA inspectors
• Documentation best practices
• Defending CAPA during audits

Wrap-Up:

• Key takeaways
• Live Q&A with expert

Who Will Benefit

• Senior management in Drugs, Devices, Biologics, Dietary Supplements
• QA
• RA
• R&D
• Engineering
• Production
• Operations
• Consultants; others tasked with product, process, CAPA resolution, failure investigation responsibilities